Recombinant Proteins Market

The recombinant proteins market consists of artificially produced proteins used in research, drug development, and therapeutics. Key customers include pharmaceutical and biotech companies, academic research institutes, and diagnostic laboratories. Market growth is primarily driven by increased government funding, rising R&D spending, the growing prevalence of chronic diseases, and an increasing demand for biologics and personalized medicine.